Protagonist Therapeutics, Inc

Connor, Clark & Lunn Investment Management Ltd. PTGX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

13,270

Value ($000)

1,159

Weight

0.0%

2020 Q2 - 2025 Q4 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	1,159	0.0%	13,270	12/31/2025
2024 Q2	8/9/2024	2,869	0.0%	82,791	6/30/2024
2024 Q1	5/9/2024	2,696	0.0%	93,186	3/31/2024
2023 Q4	2/9/2024	2,466	0.0%	107,542	12/31/2023
2023 Q3	11/13/2023	2,327	0.0%	139,494	9/30/2023
2023 Q2	8/10/2023	4,514	0.0%	163,425	6/30/2023
2023 Q1	5/10/2023	2,807	0.0%	122,024	3/31/2023
2022 Q4	2/10/2023	2,124	0.0%	194,704	12/31/2022
2022 Q3	11/10/2022	1,612	0.0%	191,193	9/30/2022
2020 Q2	8/13/2020	505	0.0%	28,598	6/30/2020